Updates are available Correction dated 2025-10-21
Click to view Correction: https://doi.org/10.1038/s41416-025-03237-5
-
Authors
Liu, Fu-Sheng https://orcid.org/0000-0003-1175-5209
Liu, Ying-Yi
Zhang, Shi-Kun
Zhou, Jun-Yu
Li, Jing-Hua
Li, Xiao-mian
Zhang, Ming-He
Pan, Xiao-Yu
Chai, Yi-Bo
Fang, Wei-Xian
Yuan, Tao
Yan, Xu-Yun
Chen, Xi
Wu, Tian-Gen
Ma, Wei-Jie
Liao, Bo
Jiang, Ping
Huang, Wei-Hua
Liu, Song-Mei
Guo, Shan
Yuan, Yu-Feng https://orcid.org/0000-0003-3924-3803
- License Information
-
More Information
Article History
Received: 1 November 2024
Revised: 4 July 2025
Accepted: 30 July 2025
First Online: 2 September 2025
Change Date: 10 October 2025
Change Type: Update
Change Details: The original online version of this article was revised: In the Conclusions section, the article originally read: “This study not only identified lipidomic alterations in CCA using bile samples but also established and validated a sex-related bile lipid classifier with high specificity and sensitivity for distinguishing between CCA and benign bile duct diseases.” The correct sentence is as follows (“sex-related” removed): “This study not only identified lipidomic alterations in CCA using bile samples but also established and validated a bile lipid classifier with high specificity and sensitivity for distinguishing between CCA and benign bile duct diseases.”
Change Date: 21 October 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41416-025-03237-5
Competing interests
: The authors declare no competing interests.
: The study was approved by the Medical Ethics Committee of the Clinical Trial Centre at Zhongnan Hospital, Wuhan University (Approval number: Scientific Research Ethics[2020100]). Informed consent for sample collection was obtained from all patients, and the study procedures followed the Declaration of Helsinki Guidelines.
: All the authors agree to the publication of the manuscript.
